Reed Smith’s Life Sciences Health Industry Group is pleased to offer a full-day CLE program covering hot topics and emerging litigation trends for in-house counsel at pharmaceutical and medical device companies.

Oradores:: Thomas H. Suddath Ann V. Kramer José Astigarraga Marilyn A. Moberg Gerard M. Stegmaier Nancy Bonifant Halstead Michael J. Salimbene, James M. Beck Heather A. Ritch Rocks

Tipo de evento: Educación legal continua/desarrollo profesional continuo, Seminario

Nombre de la ubicación:
Reed Smith's Philadelphia Office, Three Logan Square 1717 Arch Street, 31st Floor, Philadelphia PA 19103
Fecha/hora de inicio:
2 November 2017, 8:30 AM EDT
Fecha/hora de finalización:
2 November 2017, 4:00 PM EDT

The day will feature sessions on:

  • Government Regulatory Enforcement: Updates And Strategies
  • Lessons Learned In International Arbitration Battles
  • Digital Health: Issues and Considerations with Patient Engagement, Connected Devices, and Integrated Data
  • Product Liability Jury Trials: Trends and Recent Angles of Attack
  • Going Long: Addressing the Biggest Opportunities and Threats in Prescription Medical Product Liability Litigation
  • Jurisdiction and Venue Refresh Courtesy of Bristol-Myers and TC Heartland

It will also include a networking breakfast and lunch; a networking reception will immediately follow at 4 p.m.

Reed Smith is an accredited CLE provider in New Jersey and Pennsylvania. This course is presumptively approved for 7.2 CLE credits in New Jersey and 6 CLE credits Pennsylvania. An application for Delaware credit is pending. For lawyers licensed in New York, this course is eligible for 7 credits under New York’s Approved Jurisdiction Policy.

In-house counsel at pharmaceutical or medical device companies interested in attending should contact their Reed Smith relationship partner or Elizabeth Starrantino to register.